Pulmonary sarcoidosis
Not recruitingStudy on Efzofitimod for Treating Pulmonary Sarcoidosis in Patients
- Disease:Pulmonary sarcoidosis
- Substances:Efzofitimod
Italy- Participants:18–64 years · 65+ years
- Substances:Efzofitimod
- Sponsor:aTYR Pharma Inc.
Rare diseases
Investigational molecules
Locations
Back to Italy224 clinical trials in Siena, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on pulmonary conditions, including studies of treatments for idiopathic pulmonary fibrosis and chronic rhinosinusitis. Research also includes innovative approaches for respiratory syncytial virus prevention in older adults.
Comprehensive research into various cancer types, with emphasis on advanced therapies for lung cancer, Merkel cell carcinoma, and hematological malignancies.
Innovative trials examining treatments for heart failure prevention and obesity management, with focus on new therapeutic combinations and cardiovascular safety assessments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.